https://doi.org/10.1016/j.ejvs.2020.09.023
I
Ismaı̈l Elalamy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
461
Papers
9.3K
Citations
42
h-index
139
i10-index
Ismaı̈l Elalamy is an academic researcher from Hôpital américain de paris. The author has contributed to research in topics: Venous Thromboembolism Diagnosis and Management & Blood Coagulation and Thrombosis Mechanisms & Heparin-Induced Thrombocytopenia and Thrombosis. The author has an h-index of 42, co-authored 392 publications.
ORCID: 0000-0002-9576-1368Papers by this author
worksEditor's Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis
2020 · European Journal of Vascular and Endovascular Surgery · 675 citations
Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability
2014 · BMC Cancer · 49 citations
https://doi.org/10.1186/1471-2407-14-991
Heparin-induced thrombocytopenia: laboratory diagnosis and management.
2000 · PubMed · 41 citations
Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study
2018 · Blood Cancer Journal · 34 citations
https://doi.org/10.1038/s41408-018-0135-y
Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study
2017 · Thrombosis Journal · 25 citations
https://doi.org/10.1186/s12959-017-0131-7
Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 cases
2009 · Intensive Care Medicine · 24 citations
https://doi.org/10.1007/s00134-009-1464-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat